Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management
This is the dose tier where the mainstream conversation about peptides typically focuses, because the results are dramatic enough to generate attention while remaining achievable for most participants
Of the participants with both EHR and survey data, 125 self-reported using semaglutide, of whom 97.6% had a corroborating EHR record
Learn More Disclaimer: These statements have not been evaluated by the Food and Drug Administration
Medication Costs Shed's compounded GLP-1 medications are sourced only from licensed 503A pharmacies that meet USP standards
Medication Type The type of medication impacts how much weight loss and blood sugar control someone can expect: Semaglutide Dose Semaglutide follows a titration schedule, which basically means a healthcare provider will slowly increase the dosage over time